Businesses in the industry are always concentrating on tactics like joint ventures and the The market for biomarker technology is expected to increase rapidly worldwide. Although biomarkers have made great strides, one of the main obstacles to their clinical application is the laborious process of converting them into practical clinical assays. This market is expected to rise due to reasons like rising healthcare costs, more funding for research and development, the growing use of biomarkers for diagnostic purposes, and an increase in biomarker research.
The scale of the biomarker technologies industry was verified, and the sizes of several other dependent submarkets were estimated, using both top-down and bottom-up methods. Secondary research was used to identify the market’s major participants, and primary and secondary research was used to calculate their market revenues. While primary research involved in-depth interviews with important opinion leaders like CEOs, directors, and marketing executives, secondary research involved examining the annual and financial reports of major market competitors. Primary sources were used to verify the segment % splits, shares, and breakdowns that were calculated from secondary sources. This report presents the combined data together with in-depth inputs and analysis from us.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Biomarker Technologies Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Market details, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.
Biomarker Technologies Market based on Application:
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Other Applications
Biomarker Technologies Market based on Technology:
- Immunoassay
- PCR (Polymerase Chain Reaction)
- Imaging Technologies
- Mass Spectrometry
- Next-Generation Sequencing (NGS)
- Chromatography
- Cytogenetics
- Other Technologies
Biomarker Technologies Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Consumables and instruments are included in the Biomarker Technologies market segmentation based on product. Because consumables are essential to biomarker testing and are needed to operate different technologies, the consumables section of the market dominated the overall market. As a result, this causes this market to expand. However, due to technological improvements that have made instruments more accurate and rapid, the instruments category is expected to increase at the quickest rate throughout the projected period. Furthermore, the market expansion of biomarker technologies is aided by the growing acceptance of these technologies in a variety of scientific domains.
PCR, imaging technology, and NGS are included in the Biomarker Technologies market segmentation, which is based on profiling technique. Because it could detect genetic mutations and amplify DNA and RNA samples, the PCR segment dominated the market. Diagnostic and forensic labs, as well as medical and biological research, frequently employ PCR technology.
Cancer and infectious diseases are included in the Biomarker Technologies market segmentation based on application. The market was led by the cancer segment, which grew as a result of rising cancer biomarker incidence and increased demand for quick and effective diagnostic tools. Therefore, it is essential to disease management to use biomarkers for cancer detection, prognosis estimation, treatment response monitoring, and treatment resistance detection. In addition, the market is expected to be driven by rising pharmaceutical and diagnostic company partnerships as well as a rise in the need for customized medications.
Proteomics and genomics are included in the market segmentation of Biomarker Technologies based on research fields. Because it deals with the identification, measurement, and analysis of proteins—which are essential for the diagnosis, treatment, and prevention of many diseases—the genomics segment dominated the market. Proteomics technologies, including mass spectrometry and protein microarrays, are extensively employed in personalized medicine, clinical diagnostics, and drug discovery.
The report offers market insights by region for the following areas: North America, Europe, Asia-Pacific, and the Rest of the World. Due to the high illness burden, rising consumer awareness of biomarkers, encouraging government initiatives, technical developments, and improved healthcare infrastructure that will spur market growth, the North American biomarker technologies market is expected to dominate.
The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil are among the other key nations examined in the market study.
- This report illustrates the most vital attributes of the Biomarker Technologies Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Biomarker Technologies Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Biomarker Technologies Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Biomarker Technologies Market.
Methodology
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
- Forecasting
List of Tables
TABLE 1. BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 2. BIOMARKER TECHNOLOGIES MARKET VALUE FOR DIAGNOSTICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 3. BIOMARKER TECHNOLOGIES MARKET VALUE DRUG DISCOVERY & DEVELOPMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. BIOMARKER TECHNOLOGIES MARKET VALUE PERSONALIZED MEDICINE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. BIOMARKER TECHNOLOGIES MARKET VALUE DISEASE RISK ASSESSMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 7. BIOMARKER TECHNOLOGIES MARKET VALUE FOR IMMUNOASSAY, 2021-2030 (USD BILLION)
TABLE 8. BIOMARKER TECHNOLOGIES MARKET VALUE FOR PCR (POLYMERASE CHAIN REACTION), 2021-2030 (USD BILLION)
TABLE 9. BIOMARKER TECHNOLOGIES MARKET VALUE FOR IMAGING TECHNOLOGIES, 2021-2030 (USD BILLION)
TABLE 10. BIOMARKER TECHNOLOGIES MARKET VALUE FOR MASS SPECTROMETRY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. BIOMARKER TECHNOLOGIES MARKET VALUE FOR NEXT-GENERATION SEQUENCING (NGS), BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 12. BIOMARKER TECHNOLOGIES MARKET VALUE FOR CHROMATOGRAPHY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. BIOMARKER TECHNOLOGIES MARKET VALUE FOR CYTOGENETICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. BIOMARKER TECHNOLOGIES MARKET VALUE FOR OTHER TECHNOLOGIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 16. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 18. U.S BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 19. U.S BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 20. U.S BIOMARKER TECHNOLOGIES MARKET VALUE, BY DISEASE INDICATION, 2021-2030 (USD BILLION)
TABLE 21. CANADA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 22. CANADA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 23. MEXICO BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 24. MEXICO BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 25. EUROPE BIOMARKER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 26. EUROPE BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 27. EUROPE BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 28. GERMANY BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 29. GERMANY BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 30. U.K BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 31. U.K BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 32. FRANCE BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. FRANCE BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 34. ITALY BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 35. ITALY BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 36. SPAIN BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 37. SPAIN BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 38. ROE BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. ROE BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 40. ASIA PACIFIC BIOMARKER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 41. ASIA PACIFIC BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. ASIA PACIFIC BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 43. CHINA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 44. CHINA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 45. INDIA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 46. INDIA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 47. JAPAN BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 48. JAPAN BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 49. REST OF APAC BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 50. REST OF APAC BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 51. LATIN AMERICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 52. LATIN AMERICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 53. BRAZIL BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 54. BRAZIL BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 55. ARGENTINA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 56. ARGENTINA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 57. MIDDLE EAST AND AFRICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. MIDDLE EAST AND AFRICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 59. SAUDI ARABIA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 60. SAUDI ARABIA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 61. UAE BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 62. UAE BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 63. REST OF MIDDLE EAST AND AFRICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. REST OF MIDDLE EAST AND AFRICA BIOMARKER TECHNOLOGIES MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 65. THERMO FISHER SCIENTIFIC: FINANCIALS
TABLE 66. THERMO FISHER SCIENTIFIC: PRODUCTS & SERVICES
TABLE 67. THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS
TABLE 68. AGILENT TECHNOLOGIES: FINANCIALS
TABLE 69. AGILENT TECHNOLOGIES: PRODUCTS & SERVICES
TABLE 70. AGILENT TECHNOLOGIES: RECENT DEVELOPMENTS
TABLE 71. F. HOFFMANN-LA ROCHE LTD.: FINANCIALS
TABLE 72. F. HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES
TABLE 73. F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS
TABLE 74. DANAHER CORPORATION: FINANCIALS
TABLE 75. DANAHER CORPORATION: PRODUCTS & SERVICES
TABLE 76. DANAHER CORPORATION: RECENT DEVELOPMENTS
TABLE 77. WATERS CORPORATION: FINANCIALS
TABLE 78. WATERS CORPORATION: PRODUCTS & SERVICES
TABLE 79. WATERS CORPORATION: RECENT DEVELOPMENTS
TABLE 80. SHIMADZU CORPORATION: FINANCIALS
TABLE 81. SHIMADZU CORPORATION: PRODUCTS & SERVICES
TABLE 82. SHIMADZU CORPORATION: RECENT DEVELOPMENTS
TABLE 83. BIO-RAD LABORATORIES: FINANCIALS
TABLE 84. BIO-RAD LABORATORIES: PRODUCTS & SERVICES
TABLE 85. BIO-RAD LABORATORIES: DEVELOPMENTS
TABLE 86. QIAGEN N.V.: FINANCIALS
TABLE 87. QIAGEN N.V.: PRODUCTS & SERVICES
TABLE 88. QIAGEN N.V.: RECENT DEVELOPMENTS
TABLE 89. PERKINELMER, INC.: FINANCIALS
TABLE 90. PERKINELMER, INC.: PRODUCTS & SERVICES
TABLE 91. PERKINELMER, INC.: RECENT DEVELOPMENTS
TABLE 92. MERCK KGAA: FINANCIALS
TABLE 93. MERCK KGAA: PRODUCTS & SERVICES
TABLE 94. MERCK KGAA: RECENT DEVELOPMENTS
